Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1340425
European Journal of Endocrinology, Vol 134, Issue 4, 425-426
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofbauer, L. C
Right arrow Articles by Heufelder, A. E
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hofbauer, L. C
Right arrow Articles by Heufelder, A. E

Intercellular chatter: osteoblasts, osteoclasts and interleukin 6

Lorenz C Hofbauer and Armin E Heufelder

Homeostasis of bone metabolism and function depends upon bone remodeling, a coordinated, closely coupled process of resorption and formation of new bone. A variety of cell types and functions, hormones (steroid, polypeptide and thyroid hormones), as well as autocrine and paracrine growth factors and cytokines, act in concert to rebuild the skeleton while maintaining its structural and biomechanical properties (1). The two major players involved in bone remodeling, osteoblasts and osteoclasts, are of different origin: osteoblasts derive from pluripotent mesenchymal stem cells of the bone marrow, whereas osteoclasts originate from the hematopoietic granulocyte-macrophage colony-forming units (GM-CFU) (1). Thus, their differentiation to mature bone cells differs substantially with respect to their cytokine requirements and subsequent events of signal transduction.

In addition to their phenotypic markers, collagen type I and alkaline phosphatase, osteoblasts produce a variety of cytokines that are crucial for their maturation, including interleukin 6 (IL-6), IL-11, granulocytemacrophage colony-stimulating factor




This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
M. Forseni, D. Bagger-Sjoback, and M. Hultcrantz
A Study of Inflammatory Mediators in the Human Tympanosclerotic Middle Ear
Arch Otolaryngol Head Neck Surg, May 1, 2001; 127(5): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. L. Bost, J. L. Bento, J. K. Ellington, I. Marriott, and M. C. Hudson
Induction of Colony-Stimulating Factor Expression following Staphylococcus or Salmonella Interaction with Mouse or Human Osteoblasts
Infect. Immun., September 1, 2000; 68(9): 5075 - 5083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.